12:00 AM
Jun 16, 2014
 |  BC Week In Review  |  Company News  |  Management Tracks

BrainStorm management update

BrainStorm Cell Therapeutics Inc. (OTCQB:BCLI), New York, N.Y.
Business: Neurology

Read the full 32 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >